Universe Pharmaceuticals (NYSE:UPC) Stock Price Down 13.3% – Should You Sell?

Universe Pharmaceuticals INC (NYSE:UPC) shares were down 13.3% during mid-day trading on Friday . The company traded as low as $0.12 and last traded at $0.14. Approximately 2,142,620 shares were traded during trading, an increase of 89% from the average daily volume of 1,136,569 shares. The stock had previously closed at $0.16.

Universe Pharmaceuticals Stock Performance

The company has a 50-day simple moving average of $7.15 and a 200 day simple moving average of $31.61. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.63 and a quick ratio of 1.46.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Universe Pharmaceuticals stock. MML Investors Services LLC purchased a new position in Universe Pharmaceuticals INC (NYSE:UPC) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 234,260 shares of the company’s stock, valued at approximately $57,000. MML Investors Services LLC owned about 6.46% of Universe Pharmaceuticals at the end of the most recent quarter. 0.18% of the stock is currently owned by institutional investors and hedge funds.

Universe Pharmaceuticals Company Profile

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.